<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>MINOCIN- minocycline hydrochlorideÂ injectionÂ </strong><br>The Medicines Company<br></p></div>
<h1>
<span class="Bold">MINOCIN<span class="Sup">Â®</span></span><br><span class="Bold">Minocycline For Injection</span><br><span class="Bold">100 Mg/Vial</span><br>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_b0f9e590-a637-4040-a2ca-954e03c48fe2"></a><a name="section-1"></a><p></p>
<h1><span class="Bold">Rx Only</span></h1>
<p class="First">To reduce the development of drug-resistant bacteria and maintain the effectiveness of MINOCIN<span class="Sup">Â® </span>(minocycline) forÂ Injection and other antibacterial drugs, MINOCIN<span class="Sup">Â®</span> (minocycline) forÂ injection should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by bacteria.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="LINK_09d2b2d7-f7ec-4ca4-9eca-3e51d85eabc3"></a><a name="section-2"></a><p></p>
<h1><span class="Bold">DESCRIPTION</span></h1>
<p class="First">MINOCIN (minocycline) for Injection, is a sterile formulation of a semisynthetic derivative of tetracycline. The chemical name of minocycline is 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a- tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride.</p>
<p>Its structural formula is:</p>
<div class="Figure"><img alt="Structural Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=84acbae4-d385-49d0-9e7b-5ae0e8de3053&amp;name=minocin-iv-1.jpg"></div>
<p>C<span class="Sub">23</span>H<span class="Sub">27</span>N<span class="Sub">3</span>O<span class="Sub">7</span>â€¢HClÂ Â Â M.W. 493.94</p>
<p>MINOCIN is supplied as a sterile yellow to amber lyophilized powder for intravenous infusion. Each vial contains minocycline HCl equivalent to 100Â mg minocycline, 269Â mg magnesium sulfate heptahydrate (2.2Â mEq of magnesium) (an inactive ingredient) and sodium hydroxide (to adjust pH). When reconstituted with 5Â mL of Sterile Water for Injection USP the pH ranges from 4.5 to 5.0.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="LINK_b3949918-0529-4b8d-a852-f54098669794"></a><a name="section-3"></a><p></p>
<h1><span class="Bold">CLINICAL PHARMACOLOGY</span></h1>
<p class="First">Following a single dose of Minocin 200Â mg administered intravenously to 10Â healthy male subjects, serum concentrations of minocycline ranged from 2.52 to 6.63Â mcg/mL (average 4.18Â mcg/mL) at the end of infusion and 0.82 to 2.64Â mcg/mL (average 1.38 mcg/mL) after 12Â hours. In a group of 5 healthy male subjects, serum concentrations of minocycline ranged from 1.4 to1.8Â mcg/mL at the end of the dosing interval following administration of Minocin 100Â mg every 12Â hours for three days. When Minocin 200Â mg once daily was administered for three days, serum concentrations of minocycline were approximately 1Â mcg/mL at 24Â hours. The serum elimination half-life of minocycline following administration of either Minocin 100Â mg every 12Â hours or 200Â mg once daily was not significantly different and ranged from 15 to 23Â hours. The serum elimination half-life of minocycline ranged from 11 to 16Â hours in subjects with <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">hepatic impairment</span> (n=7) and 18 to 69Â hours in subjects with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> (n=5). In comparison, the serum elimination half-life of minocycline ranged from 11 to 17Â hours following a single dose of oral minocycline 200Â mg in healthy subjects (n=12).</p>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_19cc0768-34d7-4878-bbef-8d6c58fbc444"></a><a name="section-3.1"></a><p></p>
<h2><span class="Bold">Microbiology</span></h2>
<p class="First"><span class="Bold">Mechanism of Action</span><br>The tetracyclines are primarily bacteriostatic and are thought to exert their antimicrobial effect by the inhibition of protein synthesis. The tetracyclines, including minocycline, have a similar antimicrobial spectrum of activity against a wide range of Gram-positive and Gram-negative bacteria. Cross-resistance of these bacteria to tetracyclines is common.</p>
<p><span class="Bold">List of Microorganisms<br></span>Minocycline has been shown to be active against most isolates of the following bacteria, both <span class="Italics">inÂ vitro</span> and in clinical <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> as described in the <span class="Bold"><a href="#LINK_f6605d40-3bcb-4081-91bb-92737d47f329">INDICATIONS AND USAGE</a></span> section:</p>
<p><span class="Bold">Gram-positive Bacteria<br></span><span class="Italics">Bacillus anthracis</span><br><span class="Italics">Listeria monocytogenes</span><br><span class="Italics">Staphylococcus aureus</span><br><span class="Italics">Streptococcus pneumoniae</span></p>
<p><span class="Bold">Gram-negative Bacteria<br></span><span class="Italics">Bartonella bacilliformis</span><br><span class="Italics">Brucella</span> species<br><span class="Italics">Klebsiella granulomatis</span><br><span class="Italics">Campylobacter fetus</span><br><span class="Italics">Francisella tularensis</span><br><span class="Italics">Vibrio cholerae</span><br><span class="Italics">Yersinia pestis<br></span><span class="Italics">Acinetobacter </span>species <br><span class="Italics">Enterobacter aerogenes <br>Escherichia coli <br>Haemophilus influenzae<br>Klebsiella </span>species<br><span class="Italics">Neisseria meningitidis<br></span><span class="Italics">Shigella </span>species</p>
<p><span class="Bold">Other Microorganisms<br></span><span class="Italics">Actinomyces </span>species<br><span class="Italics">Borrelia recurrentis <br>Chlamydophila psittaci <br>Chlamydia trachomatis <br>Clostridium </span>species<br><span class="Italics">Entamoeba </span>species<br><span class="Italics">Fusobacterium nucleatum </span>subspecies <span class="Italics">fusiforme<br></span><span class="Italics">Myc</span><span class="Italics">obacterium marinum <br>Mycoplasma pneumoniae<br>Propionibacterium <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acnes</span> <br>Rickettsiae</span><br><span class="Italics">T</span><span class="Italics">reponema pallidum </span>subspecies <span class="Italics">pallidum<br></span><span class="Italics">T</span><span class="Italics">reponema pallidum </span>subspecies <span class="Italics">pertenue<br></span><span class="Italics">Ureaplasma urealyticum</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_9d182f68-b087-4e7a-92a8-5838ff19a480"></a><a name="section-3.2"></a><p></p>
<h2>Susceptibility Test Methods

â€‹</h2>
<p class="First">When available, the clinical microbiology laboratory should provide the results of <span class="Italics">in vitro</span> susceptibility test results for antimicrobial drugs used in resident hospitals to the physician as periodic reports that describe the susceptibility profile of nosocomial and community-acquired pathogens. These reports should aid the physician in selecting an antibacterial drug for treatment.</p>
<p><span class="Italics">Dilution Techniques<br></span>Quantitative methods are used to determine antimicrobial minimal inhibitory concentrations (MICs). These MICs provide estimates of the susceptibility of bacteria to antimicrobial compounds. The MICs should be determined using a standardized method (broth or agar) or equivalent with standardized inoculum concentrations and standardized concentrations of tetracycline or minocycline powder.<span class="Sup">1,2</span> The MIC values should be interpreted according to the criteria provided in TableÂ 1.</p>
<p><span class="Italics">Diffusion techniques<br></span>Quantitative methods that require measurement of zone diameters also provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. The zone size provides an estimate of the susceptibility of bacteria to antimicrobial compounds. The zone size should be determined using a standardized method.<span class="Sup">2,3</span> This procedure uses paper disks impregnated with 30Â mcg tetracycline or 30Â mcg minocycline to test the susceptibility of microorganisms to minocycline. The disk diffusion interpretive criteria are provided in TableÂ 1.</p>
<table width="700px">
<caption><span>Table 1: Susceptibility Test Interpretive Criteria for Minocycline and Tetracycline</span></caption>
<col>
<col>
<col>
<col>
<col>
<col>
<col>
<col>
<col>
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" rowspan="2">Â <span class="Bold">Species</span><br>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" colspan="3">
<span class="Bold">Minimal Inhibitory<br></span><span class="Bold">ConcentrationÂ <br></span><span class="Bold">(mcg/mL)</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" colspan="3">
<span class="Bold">ZoneÂ <br></span><span class="Bold">DiameterÂ <br></span><span class="Bold">(mm)</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center" colspan="3">
<span class="Bold">AgarÂ <br></span><span class="Bold">Dilution</span><br><span class="Bold">(mcg/mL)</span>
</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" align="center">Â <span class="Bold">S</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â <span class="Bold">I</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â <span class="Bold">R</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â <span class="Bold">S</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â <span class="Bold">I</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â <span class="Bold">R</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â <span class="Bold">S</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â <span class="Bold">I</span>
</td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â <span class="Bold">R</span>
</td>
</tr>
<tr>
<td class="Lrule Rrule"><span class="Italics">Enterobacteriaceae<span class="Sup">a</span></span></td>
<td class="Lrule Rrule Toprule" align="center">Â </td>
<td class="Lrule Rrule" align="center">Â </td>
<td class="Lrule Rrule" align="center">Â </td>
<td class="Lrule Rrule" align="center">Â </td>
<td class="Lrule Rrule" align="center">Â </td>
<td class="Lrule Rrule" align="center">Â </td>
<td class="Lrule Rrule" align="center">Â </td>
<td class="Lrule Rrule" align="center">Â </td>
<td class="Lrule Rrule" align="center">Â </td>
</tr>
<tr>
<td class="Lrule Rrule">Â  Â Minocycline</td>
<td class="Lrule Rrule" align="center">Â â‰¤ 4</td>
<td class="Lrule Rrule" align="center">Â 8</td>
<td class="Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Lrule Rrule" align="center">Â 13 â€“ 15 </td>
<td class="Lrule Rrule" align="center">Â â‰¤ 12</td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">Â Â  Tetracycline</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 4</td>
<td class="Botrule Lrule Rrule" align="center">Â 8</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥15</td>
<td class="Botrule Lrule Rrule" align="center">Â 12 â€“ 14</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 11</td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Lrule Rrule"><span class="Italics">Acinetobacter<span class="Sup">a</span></span></td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Lrule Rrule">Â Â  Minocycline</td>
<td class="Lrule Rrule" align="center">Â â‰¤ 4</td>
<td class="Lrule Rrule" align="center">Â 8</td>
<td class="Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Lrule Rrule" align="center">Â 13 â€“ 15 </td>
<td class="Lrule Rrule" align="center">Â â‰¤ 12</td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">Â Â  Tetracycline</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 4</td>
<td class="Botrule Lrule Rrule" align="center">Â 8</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥15</td>
<td class="Botrule Lrule Rrule" align="center">Â 12 - 14</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 11</td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Lrule Rrule"><span class="Italics">Haemophilus influenzae</span></td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">Â Â  Tetracycline</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 2</td>
<td class="Botrule Lrule Rrule" align="center">Â 4</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥8</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥29</td>
<td class="Botrule Lrule Rrule" align="center">Â 26 - 28</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 25</td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Lrule Rrule"><span class="Italics">Streptococcus pneumoniae<span class="Sup">,</span></span></td>
<td class="Lrule Rrule"></td>
<td>Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">Â Â  Tetracycline</td>
<td class="Botrule Lrule Rrule" align="center">â‰¤1Â </td>
<td class="Botrule Lrule Rrule" align="center">Â 2</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥4</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥28</td>
<td class="Botrule Lrule Rrule" align="center">Â 25 - 27</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 24</td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Lrule Rrule"><span class="Italics">Staphylococcus aureus<span class="Sup">a</span></span></td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Lrule Rrule">Â Â  Minocycline</td>
<td class="Lrule Rrule" align="center">Â â‰¤ 4</td>
<td class="Lrule Rrule" align="center">Â 8</td>
<td class="Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Lrule Rrule" align="center">Â â‰¥19</td>
<td class="Lrule Rrule" align="center">15 â€“ 18 </td>
<td class="Lrule Rrule" align="center">Â â‰¤ 14</td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">Â Â  Tetracycline</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 4</td>
<td class="Botrule Lrule Rrule" align="center">Â 8</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥19</td>
<td class="Botrule Lrule Rrule" align="center">15 â€“ 18</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 14</td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Lrule Rrule"><span class="Italics">Vibrio cholerae<span class="Sup">a</span></span></td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Lrule Rrule">Â  Â Minocycline</td>
<td class="Lrule Rrule" align="center">Â â‰¤ 4</td>
<td class="Lrule Rrule" align="center">Â 8</td>
<td class="Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Lrule Rrule" align="center">13 â€“ 15 </td>
<td class="Lrule Rrule" align="center">Â â‰¤ 12</td>
<td class="Lrule Rrule" align="center">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">Â  Â Tetracycline</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 4</td>
<td class="Botrule Lrule Rrule" align="center">Â 8</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥19</td>
<td class="Botrule Lrule Rrule" align="center">Â 15 â€“ 18 </td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 14</td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Lrule Rrule"><span class="Italics">Neisseria meningitidis<span class="Sup">b</span></span></td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">Â Â  Minocycline</td>
<td class="Botrule Lrule Rrule" align="center">Â --</td>
<td class="Botrule Lrule Rrule" align="center">Â --</td>
<td class="Botrule Lrule Rrule" align="center">Â --</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥26</td>
<td class="Botrule Lrule Rrule" align="center">Â --</td>
<td class="Botrule Lrule Rrule" align="center">Â --</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 2</td>
<td class="Botrule Lrule Rrule" align="center">Â --</td>
<td class="Botrule Lrule Rrule" align="center">Â --</td>
</tr>
<tr>
<td class="Lrule Rrule"><span class="Italics">Bacillus anthracis<span class="Sup">b</span></span></td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">Â Â  Tetracycline</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 1</td>
<td class="Botrule Lrule Rrule" align="center">Â --</td>
<td class="Botrule Lrule Rrule" align="center">Â --</td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Lrule Rrule">
<span class="Italics">Francisella tularensis<span class="Sup">b</span></span>Â  </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">Â Â  Tetracycline</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 4</td>
<td class="Botrule Lrule Rrule" align="center">Â --</td>
<td class="Botrule Lrule Rrule" align="center">Â --</td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
</tr>
<tr>
<td class="Lrule Rrule"><span class="Italics">Yersinia pestis</span></td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
<td class="Lrule Rrule">Â </td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule">Â Â  Tetracycline</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¤ 4</td>
<td class="Botrule Lrule Rrule" align="center">Â 8</td>
<td class="Botrule Lrule Rrule" align="center">Â â‰¥16</td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
<td class="Botrule Lrule Rrule">Â </td>
</tr>
</tbody>
</table>
<p><span class="Sup">a </span>Organisms that are susceptible to tetracycline are also considered susceptible to minocycline. However, some organisms that are intermediate or resistant to tetracycline may be susceptible to minocycline.<br><span class="Sup">b</span> The current absence of resistance isolates precludes defining any result other than â€œsusceptibleâ€?. If isolates yielding MIC results other than susceptible, they should be submitted to a reference laboratory for further testing.</p>
<p>A report of â€œSusceptibleâ€? indicates that the antimicrobial drug is likely to inhibit growth of the microorganism if the antimicrobial compound reaches the concentrations usually achievable at the site of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>. A report of â€œIntermediateâ€? indicates that the result should be considered equivocal, and, if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where high dosage of drug can be used. This category also provides a buffer zone which prevents small uncontrolled technical factors from causing major discrepancies in interpretation. A report of â€œResistantâ€? indicates that the antimicrobial drug is not likely to inhibit growth of the microorganism, if the antimicrobial drug reaches the concentrations usually achievable at the site of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>; other therapy should be selected.</p>
<p><span class="Italics">Quality Control<br></span>Standardized susceptibility test procedures require the use of laboratory controls to monitor and ensure the accuracy and precision of supplies and reagents used in the assay, and the techniques of the individuals performing the test. <span class="Sup">1,2,3</span> Standard tetracycline (class compound) or minocycline powder should provide the following range of MIC values noted in TableÂ 2. For the disk diffusion technique, using the 30Â mcg tetracycline or 30Â mcg minocycline disk, the criteria in TableÂ 2 should be achieved.</p>
<table cellpadding="0" cellspacing="0" width="700px">
<caption><span>Table 2: Acceptable Quality Control Ranges for Minocycline and Tetracycline</span></caption>
<col width="48.14%">
<col width="20.26%">
<col width="20.26%">
<col width="20.26%">
<thead><tr class="First Last">
<td class="Botrule Lrule Rrule Toprule"><p class="First"><span class="Bold">Species</span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First"><span class="Bold">Minimal Inhibitory<br></span><span class="Bold">Concentration <br></span><span class="Bold">(mcg/mL)</span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First"><span class="Bold">Zone <br></span><span class="Bold">Diameter <br></span><span class="Bold">(mm)</span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First"><span class="Bold">Agar <br></span><span class="Bold">Dilution<br></span><span class="Bold">(mcg/mL)</span></p></td>
</tr></thead>
<tbody>
<tr class="First">
<td class="Botrule Lrule Rrule Toprule"><p class="First"><span class="Italics">Enterococcus faecalis </span>ATCC 29212<br>Â Â Â Â  Minocycline<br>Â Â Â Â  Tetracycline</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â  <br>1 â€“ 4<br>8 â€“ 32</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â Â  <br>--<br>--</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â  <br>--<br>--</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule"><p class="First"><span class="Italics">Escherichia coli </span>ATCC 25922<br>Â Â Â Â  Minocycline<br>Â Â Â Â Â Tetracycline</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â  <br>0.25 â€“ 1<br>0.5 â€“ 2 </p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â Â  <br>19 - 25<br>18 - 25</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â  <br>--<br>--</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule"><p class="First"><span class="Italics">Haemophilus influenzae </span>ATCC 49247<br>Â Â Â Â  Tetracycline</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â  <br>4 â€“ 32</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â  <br>14 - 22</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â  <br>--</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule"><p class="First"><span class="Italics">Neisseria gonorrhoeae </span>ATCC 49226<br>Â Â Â Â  Tetracycline</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â  <br>--</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â  <br>30 - 42</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â Â  <br>0.25 â€“ 1</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule"><p class="First"><span class="Italics">Staphylococcus aureus </span>ATCC 25923<br>Â Â Â Â  Minocycline<br>Â Â Â Â  Tetracycline</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â Â Â  </td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â  <br>25 â€“ 30<br>24 - 30</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â  <br>--<br>--</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule">
<span class="Italics">Staphylococcus aureus </span>ATCC 29213<br>Â Â Â  Â Minocycline<br>Â Â Â Â  Tetracycline</td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â Â Â  <br>0.06 â€“ 0.5<br>0.12 â€“ 1</td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â Â Â Â  Â </td>
<td class="Botrule Lrule Rrule Toprule" align="center">Â Â Â  <br>--<br>--</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule Toprule"><p class="First"><span class="Italics">Streptococcus pneumoniae ATCC 49619<br>Â Â Â Â  </span>Tetracycline</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â  <br>0.06 â€“ 0.5</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â Â Â  <br>27 - 31</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center"><p class="First">Â Â  <br>--</p></td>
</tr>
</tbody>
</table>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="LINK_3d0eedea-000b-4f29-b45a-f7a08067e577"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">MINOCIN<span class="Sup">Â®</span> Intravenous is indicated in the treatment of the following <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> due to susceptible isolates of the designated bacteria:</p>
<p>Rocky Mountain spotted <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, typhus <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> and the typhus group, Q <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, rickettsialpox and tick <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fevers</span> caused by rickettsiae.<br><span class="product-label-link" type="condition" conceptid="4170143" conceptname="Respiratory tract infection">Respiratory tract infections</span> caused by <span class="Italics">Mycoplasma pneumoniae</span>. <br>Lymphogranuloma venereum caused by <span class="Italics">Chlamydia trachomatis</span>. <br>Psittacosis (Ornithosis) due to <span class="Italics">Chlamydophila psittaci</span>.<br>Trachoma caused by <span class="Italics">Chlamydia trachomatis</span>, although the infectious agent is not always eliminated, as judged by immunofluorescence.<br>Inclusion <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span> caused by <span class="Italics">Chlamydia trachomatis</span>.<br>Nongonococcal <span class="product-label-link" type="condition" conceptid="195862" conceptname="Urethritis">urethritis</span>, endocervical, or rectal <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> in adults caused by <span class="Italics">Ureaplasma urealyticum </span>or <span class="Italics">Chlamydia trachomatis.<br></span><span class="product-label-link" type="condition" conceptid="440637" conceptname="Relapsing fever">Relapsing fever</span> due to <span class="Italics">B</span><span class="Italics">orrelia recurrentis</span>. <span class="product-label-link" type="condition" conceptid="434271" conceptname="Plague">Plague</span> due to <span class="Italics">Yersinia pestis</span>.<br>Tularemia due to <span class="Italics">Francisella tularensis</span>. <br><span class="product-label-link" type="condition" conceptid="198677" conceptname="Cholera">Cholera</span> caused by <span class="Italics">Vibrio cholerae</span>.<br>Campylobacter fetus <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by <span class="Italics">Campylobacter fetus</span>. <br><span class="product-label-link" type="condition" conceptid="441497" conceptname="Brucellosis">Brucellosis</span> due to <span class="Italics">Brucella </span>species (in conjunction with streptomycin). <br>Bartonellosis due to <span class="Italics">Bartonella bacilliformis</span>.<br><span class="product-label-link" type="condition" conceptid="199726" conceptname="Granuloma inguinale">Granuloma inguinale</span> caused by <span class="Italics">Klebsiella </span><span class="Italics">granulomatis</span>.</p>
<p>Minocycline is indicated for the treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by the following Gram-negative bacteria when bacteriologic testing indicates appropriate susceptibility to the drug:</p>
<p><span class="Italics">Escherichia coli</span>. <br><span class="Italics">Enterobacter aerogenes</span>. <br><span class="Italics">Shigella </span>species. <br><span class="Italics">Acinetobacter </span>species.<br><span class="product-label-link" type="condition" conceptid="4170143" conceptname="Respiratory tract infection">Respiratory tract infections</span> caused by <span class="Italics">Haemophilus influenzae</span>. <br>Respiratory tract and <span class="product-label-link" type="condition" conceptid="81902" conceptname="Urinary tract infectious disease">urinary tract infections</span> caused by <span class="Italics">Klebsiella </span>species.</p>
<p>MINOCIN<span class="Sup">Â®</span>Â Intravenous is indicated for the treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by the following Gram-positive bacteria when bacteriologic testing indicates appropriate susceptibility to the drug:</p>
<p><span class="product-label-link" type="condition" conceptid="4181583" conceptname="Upper respiratory infection">Upper respiratory tract infections</span> caused by <span class="Italics">Streptococcus pneumoniae.<br></span>Skin and skin structure <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by <span class="Italics">Staphylococcus aureus </span>(Note: Minocycline is not the drug of choice in the treatment of any type of <span class="product-label-link" type="condition" conceptid="435459" conceptname="Staphylococcal infectious disease">staphylococcal infection</span>.)</p>
<p>When penicillin is contraindicated, minocycline is an alternative drug in the treatment of the following <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>:</p>
<p><span class="product-label-link" type="condition" conceptid="435785" conceptname="Meningitis">Meningitis</span> due to <span class="Italics">Neisseria meningitidis</span>.<br><span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">Syphilis</span> caused by <span class="Italics">Treponema pallidum </span>subspecies <span class="Italics">pallidum</span>. <br>Yaws caused by <span class="Italics">Treponema pallidum </span>subspecies <span class="Italics">pertenue</span>. <br><span class="product-label-link" type="condition" conceptid="438059" conceptname="Listeriosis">Listeriosis</span> due to <span class="Italics">L</span><span class="Italics">isteria monocytogenes</span>.<br><span class="product-label-link" type="condition" conceptid="438960" conceptname="Anthrax">Anthrax</span> due to <span class="Italics">Bacillus anthracis</span>.<br>Vincentâ€™s <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> caused by <span class="Italics">Fusobacterium fusiforme. <br></span><span class="product-label-link" type="condition" conceptid="436020" conceptname="Actinomycotic infection">Actinomycosis</span> caused by <span class="Italics">Actinomyces israelii</span>. <br><span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infections</span> caused by <span class="Italics">Clostridium </span>species.</p>
<p>In <span class="Italics">acute intestinal <span class="product-label-link" type="condition" conceptid="438959" conceptname="Amebic infection">amebiasis</span></span>, minocycline may be a useful adjunct to amebicides. </p>
<p>In severe <span class="Italics"><span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span></span>, minocycline may be useful adjunctive therapy.</p>
<p>To reduce the development of drug-resistant bacteria and maintain the effectiveness of MINOCIN<span class="Sup">Â®</span>Â (minocycline) forÂ Injection and other antibacterial drugs, MINOCIN<span class="Sup">Â®</span>Â (minocycline) forÂ Injection should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="LINK_b5275068-8ca5-4172-8a76-d688d66e341b"></a><a name="section-5"></a><p></p>
<h1>
CONTRAINDICATIONS
</h1>
<p class="First">This drug is contraindicated in persons who have shown <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the tetracyclines or to any of the components of the product formulation.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="LINK_b5aa1dec-28e9-497e-aa0d-f9dd8d2c2e4f"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><span class="Bold">Tooth Development<br></span>MINOCIN, like other tetracycline-class antibacterials, can cause fetal harm when administered to a pregnant woman. If any tetracycline is used during pregnancy, or if the patient becomes pregnant while taking these drugs, the patient should be apprised of the potential hazard to the fetus. The use of drugs of the tetracycline class during tooth development (last half of pregnancy, infancy, and childhood to the age of 8Â years) may cause permanent discoloration of the teeth (yellow-gray-brown).</p>
<p>This adverse reaction is more common during long-term use of the drugs but has been observed following repeated short-term courses. <span class="product-label-link" type="condition" conceptid="4131814" conceptname="Enamel hypoplasia">Enamel hypoplasia</span> has also been reported. Tetracycline drugs, therefore, should not be used during tooth development unless other drugs are not likely to be effective or are contraindicated.</p>
<p><span class="Bold">Skeletal Development<br></span>All tetracyclines form a stable calcium complex in any bone-forming tissue. A decrease in the fibula growth rate has been observed in premature human infants given oral tetracycline in doses of 25Â mg/kg every six hours. This reaction was shown to be reversible when the drug was discontinued.</p>
<p>Results of animal studies indicate that tetracyclines cross the placenta, are found in fetal tissues, and can have toxic effects on the developing fetus (often related to retardation of skeletal development). Evidence of embryotoxicity has been noted in animals treated early in pregnancy.</p>
<p><span class="Bold">Dermatologic Reaction<br></span><span class="product-label-link" type="condition" conceptid="4080559" conceptname="Baboon syndrome">Drug Rash</span> with <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">Eosinophilia</span> and Systemic Symptoms (DRESS) including fatal cases have been reported with minocycline use. If this syndrome is recognized, the drug should be discontinued immediately.</p>
<p><span class="Bold">Antiâ€‘anabolic Action<br></span>The anti-anabolic action of the tetracyclines may cause an increase in BUN. While this is not a problem in those with normal renal function, in patients with significantly impaired function, higher serum levels of tetracycline may lead to <span class="product-label-link" type="condition" conceptid="4261202" conceptname="Uremia">azotemia</span>, <span class="product-label-link" type="condition" conceptid="4065502" conceptname="Hyperphosphatemia">hyperphosphatemia</span>, and <span class="product-label-link" type="condition" conceptid="435517" conceptname="Acidosis">acidosis</span>. Under such conditions, monitoring of creatinine and BUN is recommended, and the total daily dosage should not exceed 200Â mg in 24Â hours (See <span class="Bold"><a href="#LINK_9d1b58cd-41d5-4083-ad8b-44e6ecaf6fd0">DOSAGE AND ADMINISTRATION</a></span>). If <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> exists, even usual oral or parenteral doses may lead to systemic accumulation of the drug and possible liver toxicity.</p>
<p><span class="Bold">P</span><span class="Bold">hotosensitivity<br></span><span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">Photosensitivity</span> manifested by an exaggerated sunburn reaction has been observed in some individuals taking tetracyclines. This has been reported with minocycline.</p>
<p><span class="Bold">Central Nervous System Effects<br></span>Central nervous system side effects including light-headedness, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span> or <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span> have been reported. Patients who experience these symptoms should be cautioned about driving vehicles or using hazardous machinery while on minocycline therapy. These symptoms may disappear during therapy and usually disappear rapidly when the drug is discontinued.</p>
<p><span class="Bold"><span class="Italics">Clostridium difficile </span>Associated <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span><br></span><span class="Italics">Clostridium difficile </span>associated <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> (CDAD) has been reported with use of nearly all antibacterial agents, including MINOCIN<span class="Sup">Â®</span>, and may range in severity from mild <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> to fatal <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span>. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of <span class="Italics">C. difficile</span>.</p>
<p><span class="Italics">C. difficile </span>produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of <span class="Italics">C. difficile </span>cause increased morbidity and mortality, as these <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> following antibacterial use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.</p>
<p>If CDAD is suspected or confirmed, ongoing antibacterial use not directed against <span class="Italics">C. difficile </span>may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of <span class="Italics">C. difficile</span>, and surgical evaluation should be instituted as clinically indicated.</p>
<p><span class="Bold"><span class="product-label-link" type="condition" conceptid="4154803" conceptname="Raised intracranial pressure">Intracranial Hypertension</span><br></span><span class="product-label-link" type="condition" conceptid="4154803" conceptname="Raised intracranial pressure">Intracranial hypertension</span> (IH, <span class="product-label-link" type="condition" conceptid="312902" conceptname="Benign intracranial hypertension">pseudotumor cerebri</span>) has been associated with the use of tetracyclines including Minocin. Clinical manifestations of IH include <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, <span class="product-label-link" type="condition" conceptid="373474" conceptname="Diplopia">diplopia</span>, and <span class="product-label-link" type="condition" conceptid="377551" conceptname="Blind hypertensive eye">vision loss</span>; <span class="product-label-link" type="condition" conceptid="4308632" conceptname="Optic disc edema">papilledema</span> can be found on fundoscopy. Women of childbearing age who are overweight or have a history of IH are at greater risk for developing tetracycline associated IH. Concomitant use of isotretinoin and Minocin should be avoided because isotretinoin is also known to cause <span class="product-label-link" type="condition" conceptid="312902" conceptname="Benign intracranial hypertension">pseudotumor cerebri</span>.</p>
<p>Although IH typically resolves after discontinuation of treatment, the possibility for permanent visual loss exists. If <span class="product-label-link" type="condition" conceptid="374034" conceptname="Visual disturbance">visual disturbance</span> occurs during treatment, prompt ophthalmologic evaluation is warranted. Since intracranial pressure can remain elevated for weeks after drug cessation patients should be monitored until they stabilize.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="LINK_3ac04419-9769-484b-a94d-92664917030c"></a><a name="section-7"></a><p></p>
<h1>
PRECAUTIONS
</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="LINK_efbe79cd-ce41-41b3-b6c7-7f058fb44698"></a><a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">As with other antibacterial preparations, use of this drug may result in overgrowth of nonsusceptible organisms, including fungi. If <span class="product-label-link" type="condition" conceptid="4105019" conceptname="Superimposed infection">superinfection</span> occurs, the antibacterial should be discontinued and appropriate therapy instituted.</p>
<p>Hepatotoxicity has been reported with minocycline; therefore, minocycline should be used with caution in patients with hepatic dysfunction and in conjunction with other hepatotoxic drugs.</p>
<p>Incision and drainage or other surgical procedures should be performed in conjunction with antibacterial therapy when indicated.</p>
<p>MINOCIN<span class="Sup">Â®</span>Â (minocycline) for Injection contains magnesium sulfate heptahydrate (See <span class="Bold"><a href="#LINK_09d2b2d7-f7ec-4ca4-9eca-3e51d85eabc3">DESCRIPTION</a></span>). Because magnesium is excreted primarily by the kidney, serum levels of magnesium should be monitored in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> (See <span class="Bold"><a href="#LINK_9d1b58cd-41d5-4083-ad8b-44e6ecaf6fd0">DOSAGE AND ADMINISTRATION</a></span>).</p>
<p>Because MINOCIN<span class="Sup">Â®</span>Â (minocycline) for Injection contains magnesium (See <span class="Bold"><a href="#LINK_09d2b2d7-f7ec-4ca4-9eca-3e51d85eabc3">DESCRIPTION</a></span>), close monitoring is recommended in patients with <span class="product-label-link" type="condition" conceptid="316135" conceptname="Atrioventricular block">heart block</span> or myocardial damage.</p>
<p>Prescribing MINOCIN<span class="Sup">Â®</span> for Injection in the absence of a proven or strongly suspected <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span> or a <span class="product-label-link" type="condition" conceptid="4118659" conceptname="Prophylactic">prophylactic</span> indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="LINK_b74142c5-a834-4236-9cf8-84c54d9f2d79"></a><a name="section-7.2"></a><p></p>
<h2>Information for Patients</h2>
<p class="First">Patients should be counseled that antibacterial drugs including MINOCIN<span class="Sup">Â®</span> (minocycline) for Injection should only be used to treat <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infections</span>. They do not treat <span class="product-label-link" type="condition" conceptid="440029" conceptname="Viral disease">viral infections</span> (e.g., the <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">common cold</span>). When MINOCIN<span class="Sup">Â®</span> (minocycline) for Injection is prescribed to treat a <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span>, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by MINOCIN<span class="Sup">Â®</span> (minocycline) for Injection or other antibacterial drugs in the future.</p>
<p><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span> is a common problem caused by antibacterials which usually ends when the antibacterial is discontinued. Sometimes after starting treatment with antibacterial drugs, patients can develop watery and <span class="product-label-link" type="condition" conceptid="443530" conceptname="Hematochezia">bloody stools</span> (with or without <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">stomach cramps</span> and <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>) even as late as two or more months after having taken the last dose of the antibacterial. If this occurs, patients should contact their physician as soon as possible.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="LINK_15f9034e-e296-460a-b7ec-cc293cc5d42f"></a><a name="section-7.3"></a><p></p>
<h2>
Laboratory Tests
</h2>
<p class="First">Periodic laboratory evaluation of organ systems, including hematopoietic, renal and hepatic studies should be performed.</p>
<p>All patients with <span class="product-label-link" type="condition" conceptid="433417" conceptname="Gonorrhea">gonorrhea</span> should have a serologic test for <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> at the time of diagnosis. Patients treated with minocycline should have a follow-up serologic test for <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> after 3Â months.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="LINK_8cc21620-1034-49dd-ac73-4299d4952565"></a><a name="section-7.4"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Because tetracyclines have been shown to depress plasma <span class="product-label-link" type="condition" conceptid="4173906" conceptname="Clotting factor II assay">prothrombin</span> activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage.</p>
<p>Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracyclines in conjunction with penicillin.</p>
<p>The concurrent use of tetracyclines and methoxyflurane has been reported to result in fatal renal toxicity.</p>
<p>Concurrent use of tetracyclines with oral contraceptives may render oral contraceptives less effective.</p>
<p>Administration of isotretinoin should be avoided shortly before, during, and shortly after minocycline therapy. Each drug alone has been associated with <span class="product-label-link" type="condition" conceptid="312902" conceptname="Benign intracranial hypertension">pseudotumor cerebri</span> (See <span class="Bold"><a href="#LINK_3c8b5298-229e-44e5-83d3-db20af872462">PRECAUTIONS</a></span>).</p>
<p>Increased risk of <span class="product-label-link" type="condition" conceptid="4201303" conceptname="Ergotism">ergotism</span> when ergot alkaloids or their derivatives are given with tetracyclines.</p>
<p>MINOCIN<span class="Sup">Â®</span>Â (minocycline) for Injection contains magnesium sulfate heptahydrate (See <span class="Bold"><a href="#LINK_09d2b2d7-f7ec-4ca4-9eca-3e51d85eabc3">DESCRIPTION</a></span>). Potentially serious drug interactions may occur when intravenous magnesium sulfate heptahydrate is given concomitantly with CNS depressants, neuromuscular blocking agents and cardiac glycosides.</p>
</div>
<div class="Section" data-sectionCode="34074-5">
<a name="LINK_64a80f04-28bf-4255-82b0-4f3792f2044c"></a><a name="section-7.5"></a><p></p>
<h2>
Drug/Laboratory Test Interactions
</h2>
<p class="First">False elevations of urinary catecholamine levels may occur due to interference with the fluorescence test.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="LINK_b0784ce8-df1e-4356-b7c6-95a283160904"></a><a name="section-7.6"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Dietary administration of minocycline in long-term tumorigenicity studies in rats resulted in evidence of <span class="product-label-link" type="condition" conceptid="4030041" conceptname="Thyroid nodule">thyroid tumor</span> production. Minocycline has also been found to produce <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">thyroid hyperplasia</span> in rats and dogs. In addition, there has been evidence of oncogenic activity in rats in studies with a related antibacterial, oxytetracycline (i.e., adrenal and pituitary tumors). Likewise, although mutagenicity studies of minocycline have not been conducted, positive results in <span class="Italics">in vitro </span>mammalian cell assays (i.e., mouse <span class="product-label-link" type="condition" conceptid="432571" conceptname="Malignant lymphoma">lymphoma</span> and Chinese hamster lung cells) have been reported for related antibacterials (tetracycline hydrochloride and oxytetracycline). Segment I (fertility and general reproduction) studies have provided evidence that minocycline impairs fertility in male rats.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="LINK_7fdc7f19-cf55-439f-b09c-f00f12171e61"></a><a name="section-7.7"></a><p></p>
<h2>Pregnancy</h2>
<p class="First"><span class="Italics">Teratogenic Effects: Pregnancy Category D</span> (See <span class="Bold"><a href="#LINK_eecca0a4-bcc2-4347-99af-1e719c45ecf0">WARNINGS</a></span>)</p>
<p>All pregnancies have a background risk of <span class="product-label-link" type="condition" conceptid="4029540" conceptname="Congenital anomaly">birth defects</span>, loss, or other adverse outcome regardless of drug exposure. There are no adequate and well-controlled studies on the use of minocycline in pregnant women. Minocycline, like other tetracycline-class antibacterials, crosses the placenta and may cause fetal harm when administered to a pregnant woman. Rare spontaneous reports of congenital anomalies including limb reduction have been reported in post-marketing experience. Only limited information is available regarding these reports; therefore, no conclusion on causal association can be established. If minocycline is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.</p>
<p><span class="Italics">Nonteratogenic Effects</span> (See <span class="Bold"><a href="#LINK_eecca0a4-bcc2-4347-99af-1e719c45ecf0">WARNINGS</a></span>)</p>
</div>
<div class="Section" data-sectionCode="34079-4">
<a name="LINK_3b6a8add-9d84-4eaf-9f79-c253488a4c24"></a><a name="section-7.8"></a><p></p>
<h2>
Labor and Delivery
</h2>
<p class="First">The effect of tetracyclines on labor and delivery is unknown.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="LINK_2ed21a5f-c659-4efa-895d-7bab00cf2236"></a><a name="section-7.9"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">Tetracyclines are excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from tetracyclines, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. (See <span class="Bold"><a href="#LINK_eecca0a4-bcc2-4347-99af-1e719c45ecf0">WARNINGS</a></span>.)</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="LINK_798e9ec2-46b2-4bf4-baed-f89ee8f95cde"></a><a name="section-7.10"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Minocycline is not recommended for use in children below 8Â years of age unless the expected benefits of therapy outweigh the risks (See <span class="Bold"><a href="#LINK_eecca0a4-bcc2-4347-99af-1e719c45ecf0">WARNINGS</a></span>).</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="LINK_7e2e1556-2412-4948-a1c0-628b37e00691"></a><a name="section-7.11"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Clinical studies of intravenous minocycline did not include sufficient numbers of subjects agedÂ 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy (See <span class="Bold"><a href="#LINK_eecca0a4-bcc2-4347-99af-1e719c45ecf0">WARNINGS</a></span>, <span class="Bold"><a href="#LINK_0a4a7814-6dce-4443-ab9c-57a9e6106a3e">DOSAGE AND ADMINISTRATION</a></span>).</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="LINK_413a2c0e-43ff-4df7-a457-160e064169a3"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">The following adverse reactions have been observed in patients receiving tetracyclines.</p>
<p><span class="Italics">Body as a whole:</span> <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span>, and discoloration of secretions.</p>
<p><span class="Italics">Gastrointestinal:</span> <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">Anorexia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">dyspepsia</span>, <span class="product-label-link" type="condition" conceptid="138455" conceptname="Stomatitis">stomatitis</span>, <span class="product-label-link" type="condition" conceptid="436147" conceptname="Glossitis">glossitis</span>, <span class="product-label-link" type="condition" conceptid="31317" conceptname="Dysphagia">dysphagia</span>, <span class="product-label-link" type="condition" conceptid="4131814" conceptname="Enamel hypoplasia">enamel hypoplasia</span>, <span class="product-label-link" type="condition" conceptid="4184503" conceptname="Enterocolitis">enterocolitis</span>, <span class="product-label-link" type="condition" conceptid="4265457" conceptname="Pseudomembranous enterocolitis">pseudomembranous colitis</span>, <span class="product-label-link" type="condition" conceptid="4192640" conceptname="Pancreatitis">pancreatitis</span>, inflammatory lesions (with monilial overgrowth) in the oral and anogenital regions. These reactions have been caused by both the oral and parenteral administration of tetracyclines.</p>
<p><span class="Italics">Genitourinary:</span> <span class="product-label-link" type="condition" conceptid="4180978" conceptname="Vulvovaginitis">Vulvovaginitis</span>.</p>
<p><span class="Italics">Hepatic toxicity:</span> <span class="product-label-link" type="condition" conceptid="4032334" conceptname="Hyperbilirubinemia">Hyperbilirubinemia</span>, hepatic <span class="product-label-link" type="condition" conceptid="4143915" conceptname="Cholestasis">cholestasis</span>, increases in liver enzymes, fatal <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">hepatic failure</span>, and <span class="product-label-link" type="condition" conceptid="137977" conceptname="Jaundice">jaundice</span>. <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">Hepatitis</span>, including <span class="product-label-link" type="condition" conceptid="200762" conceptname="Autoimmune hepatitis">autoimmune hepatitis</span>, and <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">liver failure</span> have been reported (See <span class="Bold"><a href="#LINK_3c8b5298-229e-44e5-83d3-db20af872462">PRECAUTIONS</a></span>).</p>
<p><span class="Italics">Skin:</span> <span class="product-label-link" type="condition" conceptid="133280" conceptname="Alopecia">Alopecia</span>, <span class="product-label-link" type="condition" conceptid="140176" conceptname="Erythema nodosum">erythema nodosum</span>, hyperpigmentation of nails, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="443754" conceptname="Lyell's toxic epidermal necrolysis, subepidermal type">toxic epidermal necrolysis</span>, and <span class="product-label-link" type="condition" conceptid="4137275" conceptname="Vasculitis">vasculitis</span>, maculopapular and erythematous <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rashes</span>. <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">Exfoliative dermatitis</span> has been reported. <span class="product-label-link" type="condition" conceptid="4080559" conceptname="Baboon syndrome">Fixed drug eruptions</span> have been reported. Lesions occurring on the glans penis have caused <span class="product-label-link" type="condition" conceptid="436466" conceptname="Balanoposthitis">balanitis</span>. <span class="product-label-link" type="condition" conceptid="132702" conceptname="Erythema multiforme">Erythema multiforme</span> and <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson syndrome</span> have been reported. <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">Photosensitivity</span> is discussed above (See <span class="Bold"><a href="#LINK_eecca0a4-bcc2-4347-99af-1e719c45ecf0">WARNINGS</a></span>). <span class="product-label-link" type="condition" conceptid="4083855" conceptname="Abnormal pigment">Pigmentation</span> of the skin and mucous membranes has been reported.</p>
<p><span class="Italics">Local Reactions:</span> Injection site <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> and <span class="product-label-link" type="condition" conceptid="4316207" conceptname="Injection site pain">injection site pain</span>.</p>
<p><span class="Italics">Respiratory:</span> <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">Cough</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>, <span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">bronchospasm</span>, <span class="product-label-link" type="condition" conceptid="257581" conceptname="Exacerbation of asthma">exacerbation of asthma</span>, and <span class="product-label-link" type="condition" conceptid="253506" conceptname="Pneumonitis">pneumonitis</span>.</p>
<p><span class="Italics">Renal toxicity:</span> Interstitial <span class="product-label-link" type="condition" conceptid="193253" conceptname="Nephritis">nephritis</span>. Elevations in BUN have been reported and are apparently dose related (See <span class="Bold"><a href="#LINK_eecca0a4-bcc2-4347-99af-1e719c45ecf0">WARNINGS</a></span>). <span class="product-label-link" type="condition" conceptid="197320" conceptname="Acute renal failure syndrome">Acute renal failure</span> has been reported.</p>
<p><span class="Italics">Musculoskeletal:</span> <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Arthralgia</span>, <span class="product-label-link" type="condition" conceptid="4291025" conceptname="Arthritis">arthritis</span>, bone discoloration, <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">myalgia</span>, <span class="product-label-link" type="condition" conceptid="72404" conceptname="Joint stiffness">joint stiffness</span>, and <span class="product-label-link" type="condition" conceptid="4154927" conceptname="Joint swelling">joint swelling</span>.</p>
<p><span class="Italics"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity reactions</span>:</span> <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">Urticaria</span>, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioneurotic edema</span>, <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">polyarthralgia</span>, <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>/<span class="product-label-link" type="condition" conceptid="4148381" conceptname="Anaphylactoid reaction">anaphylactoid reaction</span> (including <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span> and fatalities), <span class="product-label-link" type="condition" conceptid="4101602" conceptname="Henoch-Schonlein purpura">anaphylactoid purpura</span>, <span class="product-label-link" type="condition" conceptid="314383" conceptname="Myocarditis">myocarditis</span>, <span class="product-label-link" type="condition" conceptid="4138837" conceptname="Pericarditis">pericarditis</span>, exacerbation of <span class="product-label-link" type="condition" conceptid="257628" conceptname="Systemic lupus erythematosus">systemic lupus erythematosus</span>, and pulmonary infiltrates with <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span> have been reported. A lupus-like syndrome and <span class="product-label-link" type="condition" conceptid="432522" conceptname="Transfusion reaction due to serum protein reaction">serum sickness</span>-like reactions also have been reported.</p>
<p><span class="Italics">Blood:</span> <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">Agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">hemolytic anemia</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">leukopenia</span>, <span class="product-label-link" type="condition" conceptid="320073" conceptname="Neutropenia">neutropenia</span>, <span class="product-label-link" type="condition" conceptid="432881" conceptname="Pancytopenia">pancytopenia</span>, and <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span> have been reported.</p>
<p><span class="Italics">Central Nervous System:</span> <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">Convulsions</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="4151171" conceptname="Numbness of limbs">hypesthesia</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesia</span>, sedation, and <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span>. <span class="product-label-link" type="condition" conceptid="312902" conceptname="Benign intracranial hypertension">Pseudotumor cerebri</span> (<span class="product-label-link" type="condition" conceptid="312902" conceptname="Benign intracranial hypertension">benign intracranial hypertension</span>) in adults and bulging fontanels in infants (See <span class="Bold"><a href="#LINK_c081a8d4-4ffc-45a6-84b5-d390e4a4f8ef">PRECAUTIONS - General</a></span>). <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span> has also been reported.</p>
<p><span class="Italics">Other:</span> Thyroid cancer has been reported in the post-marketing setting in association with minocycline products. When minocycline therapyÂ is given over <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span>, monitoring for signs of thyroid cancer should be considered. When given over <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span>, tetracyclines have been reported to produce brown-black microscopic discoloration of the thyroid gland. Cases of abnormal thyroid function have been reported.</p>
<p><span class="product-label-link" type="condition" conceptid="45757361" conceptname="Mottled teeth">Tooth discoloration</span> in pediatric patients less than 8Â years of age (See <span class="Bold"><a href="#LINK_eecca0a4-bcc2-4347-99af-1e719c45ecf0">WARNINGS</a></span>) and in adults has been reported.</p>
<p>Oral cavity discoloration (including tongue, lip, and gum) have been reported.</p>
<p><span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">Tinnitus</span> and decreased hearing have been reported in patients on MINOCIN<span class="Sup">Â®</span> (minocycline for injection).</p>
<p>The following syndromes have been reported. In some cases involving these syndromes, <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> has been reported. As with other serious adverse reactions, if any of these syndromes are recognized, the drug should be discontinued immediately:</p>
<p><span class="product-label-link" type="condition" conceptid="45765791" conceptname="Drug reaction with eosinophilia and systemic symptoms">Hypersensitivity syndrome</span> consisting of cutaneous reaction (such as <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span> or <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">exfoliative dermatitis</span>), <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span>, and one or more of the following: <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, <span class="product-label-link" type="condition" conceptid="253506" conceptname="Pneumonitis">pneumonitis</span>, <span class="product-label-link" type="condition" conceptid="193253" conceptname="Nephritis">nephritis</span>, <span class="product-label-link" type="condition" conceptid="314383" conceptname="Myocarditis">myocarditis</span>, and <span class="product-label-link" type="condition" conceptid="4138837" conceptname="Pericarditis">pericarditis</span>. <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span> and <span class="product-label-link" type="condition" conceptid="315085" conceptname="Lymphadenopathy">lymphadenopathy</span> may be present.</p>
<p>Lupus-like syndrome consisting of positive <span class="product-label-link" type="condition" conceptid="4163958" conceptname="Antinuclear antibody">antinuclear antibody</span>; <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">arthralgia</span>, <span class="product-label-link" type="condition" conceptid="4291025" conceptname="Arthritis">arthritis</span>, <span class="product-label-link" type="condition" conceptid="72404" conceptname="Joint stiffness">joint stiffness</span>, or <span class="product-label-link" type="condition" conceptid="4154927" conceptname="Joint swelling">joint swelling</span>; and one or more of the following: <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">myalgia</span>, <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, and <span class="product-label-link" type="condition" conceptid="4137275" conceptname="Vasculitis">vasculitis</span>.</p>
<p><span class="product-label-link" type="condition" conceptid="432522" conceptname="Transfusion reaction due to serum protein reaction">Serum sickness</span>-like syndrome consisting of <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>; <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span> or <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>; and <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">arthralgia</span>, <span class="product-label-link" type="condition" conceptid="4291025" conceptname="Arthritis">arthritis</span>, <span class="product-label-link" type="condition" conceptid="72404" conceptname="Joint stiffness">joint stiffness</span>, or <span class="product-label-link" type="condition" conceptid="4154927" conceptname="Joint swelling">joint swelling</span>. <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">Eosinophilia</span> may be present.</p>
<p>MINOCIN<span class="Sup">Â®</span>Â (minocycline) for Injection contains magnesium sulfate heptahydrate (See <span class="Bold"><a href="#LINK_09d2b2d7-f7ec-4ca4-9eca-3e51d85eabc3">DESCRIPTION</a></span>). Adverse effects that may be associated with magnesium <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> include <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, depressed reflexes, <span class="product-label-link" type="condition" conceptid="4193951" conceptname="Flaccid paralysis">flaccid paralysis</span>, <span class="product-label-link" type="condition" conceptid="435371" conceptname="Hypothermia">hypothermia</span>, <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">circulatory collapse</span>, cardiac and <span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span> proceeding to <span class="product-label-link" type="condition" conceptid="4275136" conceptname="Paralysis of diaphragm">respiratory paralysis</span> (See <span class="Bold"><a href="#LINK_3ac04419-9769-484b-a94d-92664917030c">PRECAUTIONS</a></span>).</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="LINK_10205411-c779-4db6-a896-93b115ccd51c"></a><a name="section-9"></a><p></p>
<h1>
OVERDOSAGE
</h1>
<p class="First">The adverse events more commonly seen in <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> are <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>.</p>
<p>No specific antidote for minocycline is known.</p>
<p>In case of overdosage, discontinue medication, treat symptomatically, and institute supportive measures. Minocycline is not removed in significant quantities by hemodialysis or peritoneal dialysis.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="LINK_9d1b58cd-41d5-4083-ad8b-44e6ecaf6fd0"></a><a name="section-10"></a><p></p>
<h1>
DOSAGE AND ADMINISTRATION
</h1>
<p class="First"><span class="Bold">THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF MINOCYCLINE DIFFERS FROM THAT OF THE OTHER TETRACYCLINES. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS.</span></p>
<p>Note: Rapid administration is to be avoided. Parenteral therapy is indicated only when oral therapy is not adequate or tolerated. Oral therapy should be instituted as soon as possible. If intravenous therapy is given over <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span> of time, <span class="product-label-link" type="condition" conceptid="320741" conceptname="Thrombophlebitis">thrombophlebitis</span> may result.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_e321a709-20e2-4465-afba-eece65b7a5f7"></a><a name="section-10.1"></a><p></p>
<h2>For Pediatric Patients above 8Â years of Age</h2>
<p class="First">Usual pediatric dose: Initial dose of 4Â mg/kg, then 2Â mg/kg administered over 60Â minutes every 12Â hours, not to exceed the usual adult dose.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_63c2e31f-9854-428a-ab20-c22baebd1d74"></a><a name="section-10.2"></a><p></p>
<h2>Adults</h2>
<p class="First">Usual adult dose: Initial dose of 200Â mg, then 100Â mg administered over 60Â minutes every 12Â hours and should not exceed 400Â mg in 24Â hours.</p>
<p>The lyophilized powder should be reconstituted with 5Â mL Sterile Water for Injection USP and immediately further diluted in 100Â mL to 1,000Â mL with Sodium Chloride Injection USP, Dextrose Injection USP, or Dextrose and Sodium Chloride Injection USP, or in 250Â mL to 1000Â mL Lactated Ringerâ€™s Injection USP, but not with other solutions containing calcium because a precipitate may form especially in neutral and alkaline solutions.</p>
<p>When diluted in compatible solutions, the pH usually ranges from 4.5 to 6.0.</p>
<p>Once diluted into an intravenous bag, MINOCIN<span class="Sup">Â®</span>Â for Injection may be stored either at room temperature for up to 4Â hours or refrigerated at 2 to 8Â°C (36Â to 46Â°F) for up to 24Â hours. Any unused portions must be discarded after that period.</p>
<p>The pharmacokinetics of minocycline in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> (CLCR &lt;80Â mL/min) have not been fully characterized. Current data are insufficient to determine if a dosage adjustment is warranted. The total daily dosage should not exceed 200Â mg in 24Â hours in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span>. However, due to the anti-anabolic effect of tetracyclines, BUN and creatinine should be monitored (See <span class="Bold"><a href="#LINK_b5aa1dec-28e9-497e-aa0d-f9dd8d2c2e4f">WARNINGS</a></span>). Because MINOCIN (minocycline) for Injection contains magnesium sulfate heptahydrate, serum levels of magnesium should be monitored in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> (See <span class="Bold"><a href="#LINK_09d2b2d7-f7ec-4ca4-9eca-3e51d85eabc3">DESCRIPTION</a></span>, <span class="Bold"><a href="#LINK_3ac04419-9769-484b-a94d-92664917030c">PRECAUTIONS</a></span>).</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_e6f50e79-73bf-4d48-b0d0-84b3fe79ce4c"></a><a name="section-10.3"></a><p></p>
<h2>Incompatibilities</h2>
<p class="First">Additives or other medications should not be added to MINOCIN single-use vials or infused simultaneously through the same intravenous line including Y-connectors. If the same intravenous line is used for sequential infusion of additional medications, the line should be <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushed</span> before and after infusion of MINOCIN with Sodium Chloride Injection USP, Dextrose Injection USP, Dextrose and Sodium Chloride Injection USP, or Lactated Ringerâ€™s Injection USP.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="LINK_3000db5e-67d9-4c8e-b67c-f807c4330cd6"></a><a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">MINOCIN<span class="Sup">Â®</span> (minocycline) for Injection is supplied as 100Â mg single-use vials of sterile lyophilized powder.</p>
<p>Â Â Â Â Â  NDC Â 65293-014-01: 100Â mg single-use vial<br>Â Â Â Â Â  NDC 65293-014-10: units of 10 x 1 single-use 100 mg vials</p>
<p><span class="Bold">S</span><span class="Bold">t</span><span class="Bold">ore at Controlled Room Temperature 20Â° to 25Â°C (68Â° to 77Â°F).</span></p>
</div>
<div class="Section" data-sectionCode="34091-9">
<a name="LINK_2fa0a3c1-dc98-4794-a6b7-ee80f5c81496"></a><a name="section-12"></a><p></p>
<h1>
ANIMAL PHARMACOLOGY AND TOXICOLOGY
</h1>
<p class="First">Minocycline hydrochloride has been observed to cause a dark discoloration of the thyroid in experimental animals (rats, minipigs, dogs, and monkeys). In the rat, chronic treatment with minocycline hydrochloride has resulted in <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">goiter</span> accompanied by elevated radioactive iodine uptake and evidence of <span class="product-label-link" type="condition" conceptid="4030041" conceptname="Thyroid nodule">thyroid tumor</span> production. Minocycline hydrochloride has also been found to produce <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">thyroid hyperplasia</span> in rats and dogs.</p>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="LINK_7722f23e-a7ee-4c42-bd1c-9e2e68d20e1b"></a><a name="section-13"></a><p></p>
<h1>REFERENCES</h1>
<ol class="Arabic">
<li><p class="First">Clinical and Laboratory Standards (CLSI). <span class="Italics">Methods for Dilution Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard â€“ Ninth </span><span class="Italics">Edition</span>. CLSI document M07-A9 [2012]. Clinical and Laboratory Standards, 940 West Valley Rd., Suite 2500, Wayne, PA 19087-1898.</p></li>
<li><p class="First">Clinical and Laboratory Standards (CLSI). <span class="Italics">Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Eleventh Edition</span>. CLSI document M02-A11 [2012]. Clinical and Laboratory Standards, 940 West Valley Rd., Suite 2500, Wayne, PA 19087-1898.</p></li>
<li><p class="First">Clinical and Laboratory Standards (CLSI). <span class="Italics">Performance Standards for Antimicrobial Susceptibility Testing; Twenty-fourth Informational Supplement</span>. CLSI document M100-S24 [2014]. Clinical and Laboratory Standards, 940 West Valley Rd., Suite 2500, Wayne, PA 19087-1898.</p></li>
</ol>
<p class="First">This product's label may have been updated. For current package insert and further product information, please visit www.minociniv.com or call our toll-free number: 1-888-977-6326. Call between 9:00Â a.m. and 5:00Â p.m. Eastern Time, Monday through Friday.</p>
<p>Manufactured for Rempex Pharmaceuticals<br>A whollyâ€‘owned subsidiary of<br>The Medicines Company<br>All rights reserved.</p>
<p>Marketed and Distributed by<br>The Medicines Company<br>Parsippany, NJ 07054</p>
<p>04/15</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_b142e913-2c4f-4a05-83a0-edbf0bb057ae"></a><a name="section-14"></a><p></p>
<h1></h1>
<p class="First">Â <span class="Bold">Principal Display Panel<br></span>Â NDC 65293-014-01<br>Â Minocin<span class="Sup">Â®</span><br>Â (minocycline)<br>Â for injection<br>Â For Intravenous Infusion</p>
<div class="Figure"><img alt="NDC 65293-014-01 Minocin (minocycline) for injection For Intravenous Infusion" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=84acbae4-d385-49d0-9e7b-5ae0e8de3053&amp;name=minocin-iv-2.jpg"></div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_62ebc5df-a058-443f-ae53-b9aa144cb96a"></a><a name="section-15"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Â Principal Display Panel<br></span>Â NDC 65293-014-10<br>Â Minocin<span class="Sup">Â®</span><br>Â (minocycline)<br>Â for injection<br>Â For Intravenous Infusion<br>Â Ten Single Use Vials</p>
<p><span class="Bold"><img alt="Principal Display Panel NDC 65293-014-10 Minocin (minocycline) for injection For Intravenous Infusion Ten Single Use Vials" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=84acbae4-d385-49d0-9e7b-5ae0e8de3053&amp;name=minocin-iv-3.jpg"></span>/P%3</p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>MINOCINÂ 		
					</strong><br><span class="contentTableReg">minocycline hydrochloride injection</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:65293-014</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>MINOCYCLINE HYDROCHLORIDE</strong> (MINOCYCLINE) </td>
<td class="formItem">MINOCYCLINE</td>
<td class="formItem">100Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM SULFATE HEPTAHYDRATE</strong></td>
<td class="formItem">269Â mg</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:65293-014-10</td>
<td class="formItem">10  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:65293-014-01</td>
<td class="formItem">1  in 1 VIAL; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA050444</td>
<td class="formItem">04/19/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>The Medicines Company
							(040861601)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 4/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>a955fc21-b785-4da5-9d3e-8c709d36c816</div>
<div>Set id: 84acbae4-d385-49d0-9e7b-5ae0e8de3053</div>
<div>Version: 6</div>
<div>Effective Time: 20150430</div>
</div>
</div>Â <div class="DistributorName">The Medicines Company</div></p>
</body></html>
